Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $200.0 ...

Tandem's sales grew 3% year over year to $290 million in the fourth quarter. Worldwide shipments of its insulin pumps climbed to 38,000, including 27,000 in the U.S. The medical device maker is ...

Shares of Tandem Diabetes Care soared after the insulin-delivery and diabetes-technology company posted a loss and revenue in the fourth quarter that outperformed analysts expectations. The stock ...

Tandem Diabetes Care (NASDAQ: TNDM) shares are surging on Friday following the company’s recent financial results and guidance for 2026. The stock is moving higher as the broader market is ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...

The presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcasts and archive will be accessible on Tandem ...

An announcement from Tandem Diabetes Care ( (TNDM)) is now available. On December 26, 2025, Tandem Diabetes Care’s board of directors approved Amended and Restated Bylaws as part of a periodic ...

Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even ...

Tandem Diabetes Care (NASDAQ: TNDM), a medical device company, has had a rough year. The company's shares are down by 43%. It might be tempting to consider the stock at current levels. If it can ...